Supply of medicines

20 April 2020
Banner med ikoner for piller, coronavirus og ambulance

The COVID-19 pandemic affects the supply of medicines all over the world, and it cannot be excluded that essential medicines might face supply difficulties. The Danish Medicines Agency and AMGROS, the regions’ purchaser of medicines for hospitals, have since the outbreak of the epidemic worked closely with other relevant stakeholders to help mitigate problems with the supply of medicines in Denmark. At the European level, the Danish Medicines Agency participates on behalf of Denmark in a strategic coordination group composed of representatives from the EU member states, the European Commission and the European Medicines Agency, thus combining their efforts to mitigate supply problems at the European level.

The extraordinary situation has led to new rules being adopted. According to these rules, companies and pharmacies may be ordered to report their supplies of medicines to the Danish Medicines Agency, and the Danish Medicines Agency may also order the companies and pharmacies to spread their supplies of medicines, etc.

Even though there have not yet been reports of significant pharmaceutical supply problems caused by the COVID-19 pandemic, the authorities are planning their work based on the assumption that they will arise. Supply problems may occur, and the situation could worsen if devices and equipment are hoarded.

Since the COVID-19 outbreak in China, numerous initiatives have been launched in Denmark and internationally to counteract pharmaceutical supply problems. Among other things, restrictions on the sale of OTC and prescription-only medicines have been introduced in Denmark. Wholesalers that procure medicines for pharmacies and hospitals are also working to adjust their stocks of vital medicines.


On the same subject:

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.